Literature DB >> 16328604

A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis.

J H Krege1, K Siminoski, J D Adachi, D A Misurski, P Chen.   

Abstract

The vertebral fracture status of women with osteoporosis has strong prognostic implications that may influence clinical decisions. We developed a simple method for estimating the probability that a new vertebral fracture has occurred in postmenopausal women with osteoporosis. Data was from the placebo groups of the Fracture Prevention Trial (median observation =21 months) and the MORE Trial at 2 years. A logistic regression analysis identified prior vertebral fracture (yes/no), new or worsening back pain (yes/no), and height loss (> or =2 cm, yes/no) as significant predictors for the presence of a new vertebral fracture. The actual probability of a new vertebral fracture in patients without these predictors, over the median observation period of 23 months, was 2.1%. Presence of back pain increased this probability fourfold; prior vertebral fracture increased this probability threefold, and height loss > or =2 cm increased this probability threefold. The predicted probabilities of a new vertebral fracture being present for each subgroup representing each of the eight possible combinations of back pain, prior vertebral fracture, and height loss were highly correlated with both the multivariate logistic regression-derived probabilities (r=0.98, p <0.001) and with the actual probabilities (r=0.99, p <0.001). The validity of this simple method was confirmed in patients from the MORE trial at both 2 years and 3 years, and in the Fracture Prevention Trial alone. This simple method provides clinicians with an estimate of the probability that a new vertebral fracture has occurred in postmenopausal women with osteoporosis.

Entities:  

Mesh:

Year:  2005        PMID: 16328604     DOI: 10.1007/s00198-005-2005-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  23 in total

1.  Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989.

Authors:  C Cooper; E J Atkinson; W M O'Fallon; L J Melton
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

Review 2.  Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint.

Authors:  Robert Marcus; Mayme Wong; Hunter Heath; John L Stock
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

3.  Added value of bone mineral density in hip fracture risk scores.

Authors:  H Burger; C E de Laet; A E Weel; A Hofman; H A Pols
Journal:  Bone       Date:  1999-09       Impact factor: 4.398

4.  An assessment tool for predicting fracture risk in postmenopausal women.

Authors:  D M Black; M Steinbuch; L Palermo; P Dargent-Molina; R Lindsay; M S Hoseyni; O Johnell
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

5.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

6.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women.

Authors:  P D Ross; J W Davis; R S Epstein; R D Wasnich
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

7.  Risk of new vertebral fracture in the year following a fracture.

Authors:  R Lindsay; S L Silverman; C Cooper; D A Hanley; I Barton; S B Broy; A Licata; L Benhamou; P Geusens; K Flowers; H Stracke; E Seeman
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

8.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

9.  Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.

Authors:  K Siminoski; G Jiang; J D Adachi; D A Hanley; G Cline; G Ioannidis; A Hodsman; R G Josse; D Kendler; W P Olszynski; L-G Ste Marie; R Eastell
Journal:  Osteoporos Int       Date:  2004-08-11       Impact factor: 4.507

Review 10.  Vertebral fractures in osteoporosis: a new method for clinical assessment.

Authors:  H K Genant; J Li; C Y Wu; J A Shepherd
Journal:  J Clin Densitom       Date:  2000       Impact factor: 2.963

View more
  9 in total

1.  Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial.

Authors:  Carolyn J Crandall; Aaron K Aragaki; Meryl S LeBoff; Wenjun Li; Jean Wactawski-Wende; Jane A Cauley; Karen L Margolis; JoAnn E Manson
Journal:  Menopause       Date:  2016-12       Impact factor: 2.953

2.  Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women.

Authors:  Karine Briot; Erik Legrand; Denis Pouchain; Stéphanie Monnier; Christian Roux
Journal:  CMAJ       Date:  2010-03-22       Impact factor: 8.262

3.  Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.

Authors:  S Takahashi; M Hoshino; K Takayama; K Iseki; R Sasaoka; T Tsujio; H Yasuda; T Sasaki; F Kanematsu; H Kono; H Toyoda; H Nakamura
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

4.  Lateral back pain identifies prevalent vertebral fractures in post-menopausal women: cross-sectional analysis of a primary care-based cohort.

Authors:  Emma M Clark; Alison P Hutchinson; Eugene V McCloskey; Mike D Stone; James C Martin; Ashok K Bhalla; Jon H Tobias
Journal:  Rheumatology (Oxford)       Date:  2009-12-16       Impact factor: 7.580

5.  New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures.

Authors:  R Nuti; M L Brandi; G Isaia; U Tarantino; S Silvestri; S Adami
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

6.  Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk.

Authors:  Peiqi Chen; John H Krege; Jonathan D Adachi; Jerilynn C Prior; Alan Tenenhouse; Jacques P Brown; Emmanuel Papadimitropoulos; Nancy Kreiger; Wojciech P Olszynski; Robert G Josse; David Goltzman
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

Review 7.  Clinical value of prognostic instruments to identify patients with an increased risk for osteoporotic fractures: systematic review.

Authors:  Johann Steurer; Cyrill Haller; HansJörg Häuselmann; Florian Brunner; Lucas M Bachmann
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

8.  Serum osteoprotegerin levels are related to height loss: the Tromsø Study.

Authors:  Lone Jørgensen; John-Bjarne Hansen; Jan Brox; Ellisiv Mathiesen; Anders Vik; Bjarne K Jacobsen
Journal:  Eur J Epidemiol       Date:  2011-02-18       Impact factor: 8.082

9.  Is Retinal Microvascular Abnormalities an Independent Risk Factor of Vertebral Fractures? A Prospective Study From a Chinese Population.

Authors:  Junping Wen; Kaka Tang; Fengye Zhu; Wei Lin; Huiying Rao; Huibin Huang; Jin Yao; Ling Chen; Jixing Liang; Lixiang Lin; Hongjie Chen; Meizhi Li; Xueying Gong; Shushan Peng; Jieli Lu; Yufang Bi; Weiqing Wang; Guang Ning; Pengli Zhu; Gang Chen
Journal:  JBMR Plus       Date:  2017-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.